BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18591661)

  • 1. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations.
    Wenta N; Strauss H; Meyer S; Vinkemeier U
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9238-43. PubMed ID: 18591661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation.
    Murphy TL; Geissal ED; Farrar JD; Murphy KM
    Mol Cell Biol; 2000 Oct; 20(19):7121-31. PubMed ID: 10982828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain.
    Mertens C; Zhong M; Krishnaraj R; Zou W; Chen X; Darnell JE
    Genes Dev; 2006 Dec; 20(24):3372-81. PubMed ID: 17182865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant dimer interface mutants of STAT1 transcription factor exhibit differential gene expression.
    Staab J; Herrmann-Lingen C; Meyer T
    PLoS One; 2013; 8(7):e69903. PubMed ID: 23922848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved motif in the linker domain of STAT1 transcription factor is required for both recognition and release from high-affinity DNA-binding sites.
    Hüntelmann B; Staab J; Herrmann-Lingen C; Meyer T
    PLoS One; 2014; 9(5):e97633. PubMed ID: 24847715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two interfaces of the STAT1 N-terminus exhibit opposite functions in IFNγ-regulated gene expression.
    Staab J; Riebeling T; Koch V; Herrmann-Lingen C; Meyer T
    Mol Immunol; 2015 Oct; 67(2 Pt B):596-606. PubMed ID: 26275341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.
    Zhong M; Henriksen MA; Takeuchi K; Schaefer O; Liu B; ten Hoeve J; Ren Z; Mao X; Chen X; Shuai K; Darnell JE
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3966-71. PubMed ID: 15753310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two glutamic acid residues in the DNA-binding domain are engaged in the release of STAT1 dimers from DNA.
    Koch V; Staab J; Ruppert V; Meyer T
    BMC Cell Biol; 2012 Aug; 13():22. PubMed ID: 22920460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of stat transcription factors.
    Meyer T; Hendry L; Begitt A; John S; Vinkemeier U
    J Biol Chem; 2004 Apr; 279(18):18998-9007. PubMed ID: 15010467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
    Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA
    Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural bases of unphosphorylated STAT1 association and receptor binding.
    Mao X; Ren Z; Parker GN; Sondermann H; Pastorello MA; Wang W; McMurray JS; Demeler B; Darnell JE; Chen X
    Mol Cell; 2005 Mar; 17(6):761-71. PubMed ID: 15780933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear export determines the cytokine sensitivity of STAT transcription factors.
    Lödige I; Marg A; Wiesner B; Malecová B; Oelgeschläger T; Vinkemeier U
    J Biol Chem; 2005 Dec; 280(52):43087-99. PubMed ID: 16195225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.
    Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C
    EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding reduces the dissociation rate of STAT1 dimers and impairs the interdimeric exchange of protomers.
    Riebeling T; Staab J; Herrmann-Lingen C; Meyer T
    BMC Biochem; 2014 Dec; 15():28. PubMed ID: 25526807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation.
    Gerhartz C; Heesel B; Sasse J; Hemmann U; Landgraf C; Schneider-Mergener J; Horn F; Heinrich PC; Graeve L
    J Biol Chem; 1996 May; 271(22):12991-8. PubMed ID: 8662591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.
    Chen X; Vinkemeier U; Zhao Y; Jeruzalmi D; Darnell JE; Kuriyan J
    Cell; 1998 May; 93(5):827-39. PubMed ID: 9630226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family-wide assessment of latent STAT transcription factor interactions reveals divergent dimer repertoires.
    Begitt A; Krause S; Cavey JR; Vinkemeier DE; Vinkemeier U
    J Biol Chem; 2023 May; 299(5):104703. PubMed ID: 37059181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.
    Oda K; Matoba Y; Irie T; Kawabata R; Fukushi M; Sugiyama M; Sakaguchi T
    J Virol; 2015 Nov; 89(22):11487-99. PubMed ID: 26339056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.
    Scarzello AJ; Romero-Weaver AL; Maher SG; Veenstra TD; Zhou M; Qin A; Donnelly RP; Sheikh F; Gamero AM
    Mol Biol Cell; 2007 Jul; 18(7):2455-62. PubMed ID: 17442890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.